Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
The Journal of Pathology|July 8, 2011
PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinomaSohei Yamamoto, Hitoshi Tsuda, Masashi Takano, et al.Virchows Archiv : an International Journal of Pathology|October 27, 2009
Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathwaysSohei Yamamoto, Hitoshi Tsuda, Kosuke Miyai, et al.Cancer Science|July 9, 2010
Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progressionKosuke Miyai, Sohei Yamamoto, Tomohiko Asano, et al.Virchows Archiv : an International Journal of Pathology|August 6, 2009
An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathwaySohei Yamamoto, Hitoshi Tsuda, Kozue Suzuki, et al.Pathology International|July 6, 2007
Esophageal pleomorphic giant cell carcinoma combined with small cell carcinomaSohei Yamamoto, Hitoshi Tsuda, Takashi Sakano, et al.Human Pathology|April 20, 2007
Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometriumSohei Yamamoto, Hitoshi Tsuda, Shinsuke Aida, et al.Histopathology|June 16, 2010
Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinomaSohei Yamamoto, Hitoshi Tsuda, Kosuke Miyai, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 12, 2011
Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patientSohei Yamamoto, Hitoshi Tsuda, Kosuke Miyai, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 11, 2011
Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomasSohei Yamamoto, Hitoshi Tsuda, Kosuke Miyai, et al.BMC Cancer|October 8, 2010
HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimensHitoshi Tsuda, Masafumi Kurosumi, Shinobu Umemura, et al.Pageof 5